Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tougher FDA, Congressional “Meddling” With DSHEA Likely In 2013

This article was originally published in The Tan Sheet

Executive Summary

Compliance with GMPs and other components of DSHEA is not a priority for some firms marketing supplements in the U.S., says contract manufacturing executive Mark Le Doux. “Warning letters … keep pouring out because [firms] either didn’t read the law or they didn’t think they’d be discovered,” he says.

You may also be interested in...



FDA Works To Clarify Supplement/Food Distinction In Durbin Response

Assistant Commissioner Ireland says FDA is preparing a final guidance on distinguishing liquid supplements from conventional beverages, and a guidance on differences between supplements and foods in general could follow. She cites the challenges of distinguishing the categories in a letter responding to Senator Durbin’s questions about regulation of energy drinks.

Supplier Qualification Guideline Touts Flexibility, Defers Best Practices

The Standardized Information on Dietary Ingredients Work Group publishes a guide to help supplement firms qualify ingredient suppliers under FDA good manufacturing practices. But with only three out of five major industry associations involved, not everyone is on board with the SIDI efforts.

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

Topics

Related Companies

UsernamePublicRestriction

Register

PS106090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel